Go Back This article was viewed 88 times

Consensus Statement


What do you think are the biggest hurdles in personalized medicine in India?

Siddharth Srivastava
Department of Molecular Oncology, Neuberg Center of Genomic Medicine, Gujarat, Ahmedabad, India
Corresponding Author:

Siddharth Srivastava

Department of Molecular Oncology, Neuberg Center of Genomic Medicine, Gujarat, Ahmedabad, India
E-mail: siddharth.vastav@gmail.com

Corresponding Author:

Siddharth Srivastava

Department of Molecular Oncology, Neuberg Center of Genomic Medicine, Gujarat, Ahmedabad, India
E-mail: siddharth.vastav@gmail.com

DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20184343

ABSTRACT


Personalized medicine is highly interdisciplinary and requires people with varied skill sets to come together to deliver clinical decisions. While cost is most discussed, there are more fundamental issues that need to be resolved for successful implementation of personalized medicine in India. Following discussion focuses on personalized medicine with respect to cancer.
Keywords: Oncology molecular pathology genomics

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.